메뉴 건너뛰기




Volumn 212, Issue 4, 2015, Pages 548-549

Noninvasive prenatal testing: The importance of pretest trisomy risk and posttest predictive values

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; COUNSELING; GENETIC COUNSELING; HUMAN; LETTER; MATERNAL AGE; MATERNAL BLOOD; MATERNAL SERUM; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; TRISOMY; TRISOMY 13; TRISOMY 18; TRISOMY 21; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDERS; DOWN SYNDROME; EVALUATION STUDY; FEMALE; GENETIC SCREENING; LABORATORY DIAGNOSIS; MATERNAL SERUM SCREENING TEST; PREGNANCY; RISK ASSESSMENT; RISK FACTOR;

EID: 84930414024     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.12.033     Document Type: Letter
Times cited : (14)

References (5)
  • 1
    • 80755172331 scopus 로고    scopus 로고
    • DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
    • G.E. Palomaki, E.M. Kloza, and G.M. Lambert-Messerlian DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study Genet Med 13 2011 913 920
    • (2011) Genet Med , vol.13 , pp. 913-920
    • Palomaki, G.E.1    Kloza, E.M.2    Lambert-Messerlian, G.M.3
  • 2
    • 84908870735 scopus 로고    scopus 로고
    • Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Meta-analysis
    • M.M. Gil, R. Akolekar, M.S. Quezada, B. Bregant, and K.H. Nicolaides Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis Fetal Diagn Ther 35 2014 156 173
    • (2014) Fetal Diagn Ther , vol.35 , pp. 156-173
    • Gil, M.M.1    Akolekar, R.2    Quezada, M.S.3    Bregant, B.4    Nicolaides, K.H.5
  • 3
    • 84870156368 scopus 로고    scopus 로고
    • Noninvasive prenatal testing for fetal aneuploidy. Committee opinion no. 545
    • American College of Obstetricians and Gynecologists
    • American College of Obstetricians and Gynecologists Noninvasive prenatal testing for fetal aneuploidy. Committee opinion no. 545 Obstet Gynecol 120 2012 1532 1534
    • (2012) Obstet Gynecol , vol.120 , pp. 1532-1534
  • 4
    • 84876270082 scopus 로고    scopus 로고
    • Noninvasive prenatal testing for fetal aneuploidy: Clinical assessment and a plea for restraint
    • M.E. Norton, N.C. Rose, and P. Benn Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint Obstet Gynecol 121 2013 847 850
    • (2013) Obstet Gynecol , vol.121 , pp. 847-850
    • Norton, M.E.1    Rose, N.C.2    Benn, P.3
  • 5
    • 84886793092 scopus 로고    scopus 로고
    • Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?
    • M.T. Mennuti, A.M. Cherry, J.J. Morrissette, and L. Dugoff Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 209 2013 415 419
    • (2013) Am J Obstet Gynecol , vol.209 , pp. 415-419
    • Mennuti, M.T.1    Cherry, A.M.2    Morrissette, J.J.3    Dugoff, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.